Showing results (1061-1070 of 1,211) with videos related to

Sort By:
Pageof 122
Journal of the International AIDS Society|June 12, 2021
No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/µLAndrew Atkinson, Jose M Miro, Amanda Mocroft, et al.
Iucrj|July 22, 2024
Capturing the blue-light activated state of the Phot-LOV1 domain from Chlamydomonas reinhardtii using time-resolved serial synchrotron crystallographyGuillaume Gotthard, Sandra Mous, Tobias Weinert, et al.
HIV Medicine|July 3, 2015
Protease inhibitors to treat hepatitis C in the Swiss HIV Cohort Study: high efficacy but low treatment uptakeV Schaerer, S Haubitz, H Kovari, et al.
The Journal of Infectious Diseases|May 10, 2002
A randomized trial of simplified maintenance therapy with abacavir, lamivudine, and zidovudine in human immunodeficiency virus infectionMilos Opravil, Bernard Hirschel, Adriano Lazzarin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 12, 2024
Time Trends in Causes of Death in People With HIV: Insights From the Swiss HIV Cohort StudyM S R Weber, J J Duran Ramirez, M Hentzien, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 1, 1997
Low doses of zidovudine plus didanosine are less effective than higher doses of didanosine monotherapy: a randomized trial in patients pretreated with zidovudinePhilippe Sudre, Jean Philippe Chave, Christian Ruef, et al.
The Journal of Infectious Diseases|January 11, 2015
Assessing the Paradox Between Transmitted and Acquired HIV Type 1 Drug Resistance Mutations in the Swiss HIV Cohort Study From 1998 to 2012Wan-Lin Yang, Roger Kouyos, Alexandra U Scherrer, et al.
Open Forum Infectious Diseases|January 29, 2020
Impact of Genetic and Nongenetic Factors on Body Mass Index and Waist-Hip Ratio Change in HIV-Infected Individuals Initiating Antiretroviral TherapyCatalina Barceló, Monia Guidi, Christian W Thorball, et al.
International Journal of Antimicrobial Agents|July 3, 2017
Impact of early versus deferred antiretroviral therapy on estimated glomerular filtration rate in HIV-positive individuals in the START trialAmit C Achhra, Amanda Mocroft, Michael Ross, et al.
AIDS (London, England)|April 20, 2022
Cytomegalovirus viremia and risk of disease progression and death in HIV-positive patients starting antiretroviral therapyLaura I Levi, Shweta Sharma, Mark R Schleiss, et al.
Pageof 122